nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2B—Sorafenib—kidney cancer	0.151	0.606	CbGbCtD
Cyproheptadine—HTR2C—Sorafenib—kidney cancer	0.0982	0.394	CbGbCtD
Cyproheptadine—CHRM3—ureter—kidney cancer	0.0097	0.582	CbGeAlD
Cyproheptadine—HTR2A—urine—kidney cancer	0.00187	0.112	CbGeAlD
Cyproheptadine—Rash—Temsirolimus—kidney cancer	0.0016	0.00253	CcSEcCtD
Cyproheptadine—Dermatitis—Temsirolimus—kidney cancer	0.0016	0.00253	CcSEcCtD
Cyproheptadine—Chills—Gemcitabine—kidney cancer	0.0016	0.00253	CcSEcCtD
Cyproheptadine—Headache—Temsirolimus—kidney cancer	0.00159	0.00252	CcSEcCtD
Cyproheptadine—Decreased appetite—Erlotinib—kidney cancer	0.00158	0.0025	CcSEcCtD
Cyproheptadine—Dizziness—Pazopanib—kidney cancer	0.00158	0.0025	CcSEcCtD
Cyproheptadine—Oedema—Sunitinib—kidney cancer	0.00158	0.00249	CcSEcCtD
Cyproheptadine—Fatigue—Erlotinib—kidney cancer	0.00157	0.00248	CcSEcCtD
Cyproheptadine—Anorexia—Sorafenib—kidney cancer	0.00156	0.00247	CcSEcCtD
Cyproheptadine—Feeling abnormal—Vinblastine—kidney cancer	0.00156	0.00247	CcSEcCtD
Cyproheptadine—Constipation—Erlotinib—kidney cancer	0.00156	0.00246	CcSEcCtD
Cyproheptadine—Feeling abnormal—Everolimus—kidney cancer	0.00156	0.00246	CcSEcCtD
Cyproheptadine—Shock—Sunitinib—kidney cancer	0.00155	0.00245	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Sunitinib—kidney cancer	0.00155	0.00244	CcSEcCtD
Cyproheptadine—Vomiting—Pazopanib—kidney cancer	0.00152	0.0024	CcSEcCtD
Cyproheptadine—Rash—Pazopanib—kidney cancer	0.00151	0.00238	CcSEcCtD
Cyproheptadine—Nausea—Temsirolimus—kidney cancer	0.00151	0.00238	CcSEcCtD
Cyproheptadine—Dermatitis—Pazopanib—kidney cancer	0.00151	0.00238	CcSEcCtD
Cyproheptadine—Anorexia—Sunitinib—kidney cancer	0.0015	0.00238	CcSEcCtD
Cyproheptadine—Agitation—Vincristine—kidney cancer	0.0015	0.00238	CcSEcCtD
Cyproheptadine—Headache—Pazopanib—kidney cancer	0.0015	0.00237	CcSEcCtD
Cyproheptadine—Oedema—Dactinomycin—kidney cancer	0.00149	0.00236	CcSEcCtD
Cyproheptadine—Sweating increased—Capecitabine—kidney cancer	0.00149	0.00236	CcSEcCtD
Cyproheptadine—Vertigo—Vincristine—kidney cancer	0.00147	0.00232	CcSEcCtD
Cyproheptadine—Leukopenia—Vincristine—kidney cancer	0.00146	0.00231	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dactinomycin—kidney cancer	0.00146	0.00231	CcSEcCtD
Cyproheptadine—Dyspepsia—Sorafenib—kidney cancer	0.00144	0.00228	CcSEcCtD
Cyproheptadine—Insomnia—Sunitinib—kidney cancer	0.00143	0.00226	CcSEcCtD
Cyproheptadine—Decreased appetite—Sorafenib—kidney cancer	0.00143	0.00225	CcSEcCtD
Cyproheptadine—Anorexia—Dactinomycin—kidney cancer	0.00142	0.00225	CcSEcCtD
Cyproheptadine—Nausea—Pazopanib—kidney cancer	0.00142	0.00225	CcSEcCtD
Cyproheptadine—Paraesthesia—Sunitinib—kidney cancer	0.00142	0.00224	CcSEcCtD
Cyproheptadine—Convulsion—Vincristine—kidney cancer	0.00142	0.00224	CcSEcCtD
Cyproheptadine—Fatigue—Sorafenib—kidney cancer	0.00141	0.00223	CcSEcCtD
Cyproheptadine—Constipation—Sorafenib—kidney cancer	0.0014	0.00222	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Capecitabine—kidney cancer	0.0014	0.00221	CcSEcCtD
Cyproheptadine—Weight increased—Capecitabine—kidney cancer	0.00139	0.0022	CcSEcCtD
Cyproheptadine—Tinnitus—Paclitaxel—kidney cancer	0.00139	0.0022	CcSEcCtD
Cyproheptadine—Dyspepsia—Sunitinib—kidney cancer	0.00139	0.0022	CcSEcCtD
Cyproheptadine—Leukopenia—Gemcitabine—kidney cancer	0.00139	0.0022	CcSEcCtD
Cyproheptadine—Decreased appetite—Sunitinib—kidney cancer	0.00137	0.00217	CcSEcCtD
Cyproheptadine—Asthenia—Vinblastine—kidney cancer	0.00136	0.00215	CcSEcCtD
Cyproheptadine—Fatigue—Sunitinib—kidney cancer	0.00136	0.00215	CcSEcCtD
Cyproheptadine—Asthenia—Everolimus—kidney cancer	0.00136	0.00214	CcSEcCtD
Cyproheptadine—Constipation—Sunitinib—kidney cancer	0.00135	0.00213	CcSEcCtD
Cyproheptadine—Chills—Paclitaxel—kidney cancer	0.00134	0.00212	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Capecitabine—kidney cancer	0.00134	0.00211	CcSEcCtD
Cyproheptadine—Oedema—Vincristine—kidney cancer	0.00133	0.00211	CcSEcCtD
Cyproheptadine—Jaundice—Capecitabine—kidney cancer	0.00133	0.0021	CcSEcCtD
Cyproheptadine—Asthenia—Erlotinib—kidney cancer	0.00131	0.00207	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Vincristine—kidney cancer	0.00131	0.00207	CcSEcCtD
Cyproheptadine—Urticaria—Sorafenib—kidney cancer	0.0013	0.00206	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—kidney cancer	0.0013	0.00205	CcSEcCtD
Cyproheptadine—Decreased appetite—Dactinomycin—kidney cancer	0.0013	0.00205	CcSEcCtD
Cyproheptadine—Diarrhoea—Vinblastine—kidney cancer	0.0013	0.00205	CcSEcCtD
Cyproheptadine—Diarrhoea—Everolimus—kidney cancer	0.00129	0.00204	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Vincristine—kidney cancer	0.00129	0.00204	CcSEcCtD
Cyproheptadine—Fatigue—Dactinomycin—kidney cancer	0.00129	0.00204	CcSEcCtD
Cyproheptadine—Tension—Paclitaxel—kidney cancer	0.00127	0.00201	CcSEcCtD
Cyproheptadine—Agranulocytosis—Capecitabine—kidney cancer	0.00127	0.00201	CcSEcCtD
Cyproheptadine—Anorexia—Vincristine—kidney cancer	0.00127	0.00201	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—kidney cancer	0.00127	0.00201	CcSEcCtD
Cyproheptadine—Oedema—Gemcitabine—kidney cancer	0.00127	0.002	CcSEcCtD
Cyproheptadine—Nervousness—Paclitaxel—kidney cancer	0.00126	0.00199	CcSEcCtD
Cyproheptadine—Dizziness—Vinblastine—kidney cancer	0.00125	0.00198	CcSEcCtD
Cyproheptadine—Dizziness—Everolimus—kidney cancer	0.00125	0.00197	CcSEcCtD
Cyproheptadine—Diarrhoea—Erlotinib—kidney cancer	0.00125	0.00197	CcSEcCtD
Cyproheptadine—Hypotension—Vincristine—kidney cancer	0.00125	0.00197	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Gemcitabine—kidney cancer	0.00124	0.00196	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dactinomycin—kidney cancer	0.00123	0.00195	CcSEcCtD
Cyproheptadine—Hepatitis—Capecitabine—kidney cancer	0.00122	0.00194	CcSEcCtD
Cyproheptadine—Vision blurred—Paclitaxel—kidney cancer	0.00122	0.00194	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00122	0.00193	CcSEcCtD
Cyproheptadine—Tremor—Paclitaxel—kidney cancer	0.00122	0.00192	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—kidney cancer	0.00121	0.00192	CcSEcCtD
Cyproheptadine—Insomnia—Vincristine—kidney cancer	0.00121	0.00191	CcSEcCtD
Cyproheptadine—Anorexia—Gemcitabine—kidney cancer	0.00121	0.00191	CcSEcCtD
Cyproheptadine—Vomiting—Vinblastine—kidney cancer	0.00121	0.00191	CcSEcCtD
Cyproheptadine—Dizziness—Erlotinib—kidney cancer	0.00121	0.00191	CcSEcCtD
Cyproheptadine—Vomiting—Everolimus—kidney cancer	0.0012	0.0019	CcSEcCtD
Cyproheptadine—Paraesthesia—Vincristine—kidney cancer	0.0012	0.00189	CcSEcCtD
Cyproheptadine—Agitation—Paclitaxel—kidney cancer	0.00119	0.00189	CcSEcCtD
Cyproheptadine—Rash—Everolimus—kidney cancer	0.00119	0.00188	CcSEcCtD
Cyproheptadine—Dermatitis—Everolimus—kidney cancer	0.00119	0.00188	CcSEcCtD
Cyproheptadine—Headache—Vinblastine—kidney cancer	0.00119	0.00188	CcSEcCtD
Cyproheptadine—Headache—Everolimus—kidney cancer	0.00118	0.00187	CcSEcCtD
Cyproheptadine—Hypotension—Gemcitabine—kidney cancer	0.00118	0.00187	CcSEcCtD
Cyproheptadine—Asthenia—Sorafenib—kidney cancer	0.00118	0.00186	CcSEcCtD
Cyproheptadine—Vertigo—Paclitaxel—kidney cancer	0.00117	0.00184	CcSEcCtD
Cyproheptadine—Syncope—Paclitaxel—kidney cancer	0.00117	0.00184	CcSEcCtD
Cyproheptadine—Leukopenia—Paclitaxel—kidney cancer	0.00116	0.00184	CcSEcCtD
Cyproheptadine—Decreased appetite—Vincristine—kidney cancer	0.00116	0.00183	CcSEcCtD
Cyproheptadine—Vomiting—Erlotinib—kidney cancer	0.00116	0.00183	CcSEcCtD
Cyproheptadine—Fatigue—Vincristine—kidney cancer	0.00115	0.00182	CcSEcCtD
Cyproheptadine—Rash—Erlotinib—kidney cancer	0.00115	0.00182	CcSEcCtD
Cyproheptadine—Dermatitis—Erlotinib—kidney cancer	0.00115	0.00182	CcSEcCtD
Cyproheptadine—Palpitations—Paclitaxel—kidney cancer	0.00115	0.00181	CcSEcCtD
Cyproheptadine—Insomnia—Gemcitabine—kidney cancer	0.00115	0.00181	CcSEcCtD
Cyproheptadine—Headache—Erlotinib—kidney cancer	0.00114	0.00181	CcSEcCtD
Cyproheptadine—Tinnitus—Capecitabine—kidney cancer	0.00114	0.0018	CcSEcCtD
Cyproheptadine—Loss of consciousness—Paclitaxel—kidney cancer	0.00114	0.0018	CcSEcCtD
Cyproheptadine—Constipation—Vincristine—kidney cancer	0.00114	0.0018	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—kidney cancer	0.00114	0.0018	CcSEcCtD
Cyproheptadine—Paraesthesia—Gemcitabine—kidney cancer	0.00114	0.0018	CcSEcCtD
Cyproheptadine—Asthenia—Sunitinib—kidney cancer	0.00113	0.00179	CcSEcCtD
Cyproheptadine—Nausea—Vinblastine—kidney cancer	0.00113	0.00178	CcSEcCtD
Cyproheptadine—Somnolence—Gemcitabine—kidney cancer	0.00113	0.00178	CcSEcCtD
Cyproheptadine—Convulsion—Paclitaxel—kidney cancer	0.00113	0.00178	CcSEcCtD
Cyproheptadine—Nausea—Everolimus—kidney cancer	0.00112	0.00177	CcSEcCtD
Cyproheptadine—Diarrhoea—Sorafenib—kidney cancer	0.00112	0.00177	CcSEcCtD
Cyproheptadine—Decreased appetite—Gemcitabine—kidney cancer	0.0011	0.00174	CcSEcCtD
Cyproheptadine—Chills—Capecitabine—kidney cancer	0.0011	0.00174	CcSEcCtD
Cyproheptadine—Fatigue—Gemcitabine—kidney cancer	0.00109	0.00173	CcSEcCtD
Cyproheptadine—Dizziness—Sorafenib—kidney cancer	0.00108	0.00171	CcSEcCtD
Cyproheptadine—Constipation—Gemcitabine—kidney cancer	0.00108	0.00171	CcSEcCtD
Cyproheptadine—Nausea—Erlotinib—kidney cancer	0.00108	0.00171	CcSEcCtD
Cyproheptadine—Diarrhoea—Sunitinib—kidney cancer	0.00108	0.00171	CcSEcCtD
Cyproheptadine—Asthenia—Dactinomycin—kidney cancer	0.00107	0.00169	CcSEcCtD
Cyproheptadine—Confusional state—Paclitaxel—kidney cancer	0.00107	0.00169	CcSEcCtD
Cyproheptadine—Oedema—Paclitaxel—kidney cancer	0.00106	0.00168	CcSEcCtD
Cyproheptadine—Dizziness—Sunitinib—kidney cancer	0.00104	0.00165	CcSEcCtD
Cyproheptadine—Feeling abnormal—Gemcitabine—kidney cancer	0.00104	0.00165	CcSEcCtD
Cyproheptadine—Shock—Paclitaxel—kidney cancer	0.00104	0.00165	CcSEcCtD
Cyproheptadine—Vomiting—Sorafenib—kidney cancer	0.00104	0.00165	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Paclitaxel—kidney cancer	0.00104	0.00164	CcSEcCtD
Cyproheptadine—Tachycardia—Paclitaxel—kidney cancer	0.00103	0.00164	CcSEcCtD
Cyproheptadine—Rash—Sorafenib—kidney cancer	0.00103	0.00163	CcSEcCtD
Cyproheptadine—Dermatitis—Sorafenib—kidney cancer	0.00103	0.00163	CcSEcCtD
Cyproheptadine—Headache—Sorafenib—kidney cancer	0.00103	0.00162	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00103	0.00162	CcSEcCtD
Cyproheptadine—Diarrhoea—Dactinomycin—kidney cancer	0.00102	0.00162	CcSEcCtD
Cyproheptadine—Anorexia—Paclitaxel—kidney cancer	0.00101	0.0016	CcSEcCtD
Cyproheptadine—Vision blurred—Capecitabine—kidney cancer	0.001	0.00159	CcSEcCtD
Cyproheptadine—Vomiting—Sunitinib—kidney cancer	0.001	0.00159	CcSEcCtD
Cyproheptadine—Tremor—Capecitabine—kidney cancer	0.000999	0.00158	CcSEcCtD
Cyproheptadine—Rash—Sunitinib—kidney cancer	0.000995	0.00157	CcSEcCtD
Cyproheptadine—Dermatitis—Sunitinib—kidney cancer	0.000994	0.00157	CcSEcCtD
Cyproheptadine—Hypotension—Paclitaxel—kidney cancer	0.000991	0.00157	CcSEcCtD
Cyproheptadine—Headache—Sunitinib—kidney cancer	0.000989	0.00156	CcSEcCtD
Cyproheptadine—Nausea—Sorafenib—kidney cancer	0.000974	0.00154	CcSEcCtD
Cyproheptadine—Insomnia—Paclitaxel—kidney cancer	0.000959	0.00152	CcSEcCtD
Cyproheptadine—Vertigo—Capecitabine—kidney cancer	0.000958	0.00151	CcSEcCtD
Cyproheptadine—Asthenia—Vincristine—kidney cancer	0.000958	0.00151	CcSEcCtD
Cyproheptadine—Syncope—Capecitabine—kidney cancer	0.000956	0.00151	CcSEcCtD
Cyproheptadine—Leukopenia—Capecitabine—kidney cancer	0.000954	0.00151	CcSEcCtD
Cyproheptadine—Paraesthesia—Paclitaxel—kidney cancer	0.000952	0.0015	CcSEcCtD
Cyproheptadine—Vomiting—Dactinomycin—kidney cancer	0.00095	0.0015	CcSEcCtD
Cyproheptadine—Somnolence—Paclitaxel—kidney cancer	0.000943	0.00149	CcSEcCtD
Cyproheptadine—Palpitations—Capecitabine—kidney cancer	0.000942	0.00149	CcSEcCtD
Cyproheptadine—Rash—Dactinomycin—kidney cancer	0.000942	0.00149	CcSEcCtD
Cyproheptadine—Nausea—Sunitinib—kidney cancer	0.000938	0.00148	CcSEcCtD
Cyproheptadine—Loss of consciousness—Capecitabine—kidney cancer	0.000937	0.00148	CcSEcCtD
Cyproheptadine—Dyspepsia—Paclitaxel—kidney cancer	0.000933	0.00148	CcSEcCtD
Cyproheptadine—Decreased appetite—Paclitaxel—kidney cancer	0.000922	0.00146	CcSEcCtD
Cyproheptadine—Fatigue—Paclitaxel—kidney cancer	0.000914	0.00144	CcSEcCtD
Cyproheptadine—Diarrhoea—Vincristine—kidney cancer	0.000913	0.00144	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—kidney cancer	0.000911	0.00144	CcSEcCtD
Cyproheptadine—Asthenia—Gemcitabine—kidney cancer	0.000909	0.00144	CcSEcCtD
Cyproheptadine—Constipation—Paclitaxel—kidney cancer	0.000907	0.00143	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.0009	0.00142	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—kidney cancer	0.000898	0.00142	CcSEcCtD
Cyproheptadine—Nausea—Dactinomycin—kidney cancer	0.000888	0.0014	CcSEcCtD
Cyproheptadine—Dizziness—Vincristine—kidney cancer	0.000883	0.0014	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—kidney cancer	0.000879	0.00139	CcSEcCtD
Cyproheptadine—Confusional state—Capecitabine—kidney cancer	0.000877	0.00139	CcSEcCtD
Cyproheptadine—Feeling abnormal—Paclitaxel—kidney cancer	0.000874	0.00138	CcSEcCtD
Cyproheptadine—Oedema—Capecitabine—kidney cancer	0.00087	0.00138	CcSEcCtD
Cyproheptadine—Diarrhoea—Gemcitabine—kidney cancer	0.000867	0.00137	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000862	0.00136	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—kidney cancer	0.000857	0.00135	CcSEcCtD
Cyproheptadine—Shock—Capecitabine—kidney cancer	0.000856	0.00135	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Capecitabine—kidney cancer	0.000852	0.00135	CcSEcCtD
Cyproheptadine—Tachycardia—Capecitabine—kidney cancer	0.000849	0.00134	CcSEcCtD
Cyproheptadine—Vomiting—Vincristine—kidney cancer	0.000849	0.00134	CcSEcCtD
Cyproheptadine—Urticaria—Paclitaxel—kidney cancer	0.000842	0.00133	CcSEcCtD
Cyproheptadine—Rash—Vincristine—kidney cancer	0.000842	0.00133	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Capecitabine—kidney cancer	0.000841	0.00133	CcSEcCtD
Cyproheptadine—Dermatitis—Vincristine—kidney cancer	0.000841	0.00133	CcSEcCtD
Cyproheptadine—Headache—Vincristine—kidney cancer	0.000836	0.00132	CcSEcCtD
Cyproheptadine—Anorexia—Capecitabine—kidney cancer	0.000829	0.00131	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—kidney cancer	0.000821	0.0013	CcSEcCtD
Cyproheptadine—Hypotension—Capecitabine—kidney cancer	0.000813	0.00129	CcSEcCtD
Cyproheptadine—HTR2B—cortex of kidney—kidney cancer	0.000807	0.0485	CbGeAlD
Cyproheptadine—Vomiting—Gemcitabine—kidney cancer	0.000805	0.00127	CcSEcCtD
Cyproheptadine—Rash—Gemcitabine—kidney cancer	0.000799	0.00126	CcSEcCtD
Cyproheptadine—Dermatitis—Gemcitabine—kidney cancer	0.000798	0.00126	CcSEcCtD
Cyproheptadine—Headache—Gemcitabine—kidney cancer	0.000793	0.00125	CcSEcCtD
Cyproheptadine—Nausea—Vincristine—kidney cancer	0.000793	0.00125	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—kidney cancer	0.000789	0.00125	CcSEcCtD
Cyproheptadine—Insomnia—Capecitabine—kidney cancer	0.000787	0.00124	CcSEcCtD
Cyproheptadine—Paraesthesia—Capecitabine—kidney cancer	0.000781	0.00123	CcSEcCtD
Cyproheptadine—CHRM3—renal system—kidney cancer	0.000771	0.0463	CbGeAlD
Cyproheptadine—HTR1A—renal system—kidney cancer	0.000768	0.0461	CbGeAlD
Cyproheptadine—Dyspepsia—Capecitabine—kidney cancer	0.000766	0.00121	CcSEcCtD
Cyproheptadine—Asthenia—Paclitaxel—kidney cancer	0.000761	0.0012	CcSEcCtD
Cyproheptadine—Decreased appetite—Capecitabine—kidney cancer	0.000756	0.0012	CcSEcCtD
Cyproheptadine—Nausea—Gemcitabine—kidney cancer	0.000752	0.00119	CcSEcCtD
Cyproheptadine—Fatigue—Capecitabine—kidney cancer	0.00075	0.00119	CcSEcCtD
Cyproheptadine—CHRM3—kidney—kidney cancer	0.000746	0.0448	CbGeAlD
Cyproheptadine—Constipation—Capecitabine—kidney cancer	0.000744	0.00118	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—kidney cancer	0.000736	0.00116	CcSEcCtD
Cyproheptadine—Diarrhoea—Paclitaxel—kidney cancer	0.000725	0.00115	CcSEcCtD
Cyproheptadine—Feeling abnormal—Capecitabine—kidney cancer	0.000717	0.00113	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—kidney cancer	0.000708	0.00112	CcSEcCtD
Cyproheptadine—Dizziness—Paclitaxel—kidney cancer	0.000701	0.00111	CcSEcCtD
Cyproheptadine—Urticaria—Capecitabine—kidney cancer	0.000691	0.00109	CcSEcCtD
Cyproheptadine—SLC6A2—gonad—kidney cancer	0.000683	0.041	CbGeAlD
Cyproheptadine—Tension—Doxorubicin—kidney cancer	0.000674	0.00107	CcSEcCtD
Cyproheptadine—Vomiting—Paclitaxel—kidney cancer	0.000674	0.00107	CcSEcCtD
Cyproheptadine—Rash—Paclitaxel—kidney cancer	0.000669	0.00106	CcSEcCtD
Cyproheptadine—Dermatitis—Paclitaxel—kidney cancer	0.000668	0.00106	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—kidney cancer	0.000668	0.00105	CcSEcCtD
Cyproheptadine—Headache—Paclitaxel—kidney cancer	0.000664	0.00105	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—kidney cancer	0.000648	0.00102	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—kidney cancer	0.000632	0.000998	CcSEcCtD
Cyproheptadine—Nausea—Paclitaxel—kidney cancer	0.00063	0.000995	CcSEcCtD
Cyproheptadine—Asthenia—Capecitabine—kidney cancer	0.000624	0.000987	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—kidney cancer	0.000617	0.000976	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—kidney cancer	0.000616	0.000974	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—kidney cancer	0.000615	0.000972	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—kidney cancer	0.000607	0.00096	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—kidney cancer	0.000604	0.000955	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—kidney cancer	0.000595	0.000941	CcSEcCtD
Cyproheptadine—Diarrhoea—Capecitabine—kidney cancer	0.000595	0.000941	CcSEcCtD
Cyproheptadine—Dizziness—Capecitabine—kidney cancer	0.000575	0.000909	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—kidney cancer	0.000566	0.000894	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—kidney cancer	0.000561	0.000886	CcSEcCtD
Cyproheptadine—Vomiting—Capecitabine—kidney cancer	0.000553	0.000874	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—kidney cancer	0.000552	0.000872	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000549	0.000868	CcSEcCtD
Cyproheptadine—Rash—Capecitabine—kidney cancer	0.000549	0.000867	CcSEcCtD
Cyproheptadine—Dermatitis—Capecitabine—kidney cancer	0.000548	0.000866	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—kidney cancer	0.000547	0.000865	CcSEcCtD
Cyproheptadine—Headache—Capecitabine—kidney cancer	0.000545	0.000862	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000542	0.000857	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—kidney cancer	0.000535	0.000845	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—kidney cancer	0.000524	0.000828	CcSEcCtD
Cyproheptadine—Nausea—Capecitabine—kidney cancer	0.000517	0.000817	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—kidney cancer	0.000507	0.000802	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—kidney cancer	0.000504	0.000796	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—kidney cancer	0.000499	0.000788	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—kidney cancer	0.000494	0.00078	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—kidney cancer	0.000488	0.000771	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—kidney cancer	0.000484	0.000764	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—kidney cancer	0.00048	0.000758	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—kidney cancer	0.000462	0.00073	CcSEcCtD
Cyproheptadine—HTR2A—renal system—kidney cancer	0.000458	0.0275	CbGeAlD
Cyproheptadine—Urticaria—Doxorubicin—kidney cancer	0.000446	0.000704	CcSEcCtD
Cyproheptadine—HTR2A—kidney—kidney cancer	0.000443	0.0266	CbGeAlD
Cyproheptadine—HTR2A—gonad—kidney cancer	0.000411	0.0246	CbGeAlD
Cyproheptadine—Asthenia—Doxorubicin—kidney cancer	0.000402	0.000636	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—kidney cancer	0.000384	0.000607	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—kidney cancer	0.000371	0.000586	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—kidney cancer	0.000357	0.000564	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—kidney cancer	0.000354	0.000559	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—kidney cancer	0.000353	0.000558	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—kidney cancer	0.000351	0.000555	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—kidney cancer	0.000333	0.000527	CcSEcCtD
Cyproheptadine—Protriptyline—ABCB1—kidney cancer	0.000303	0.299	CrCbGaD
Cyproheptadine—Nortriptyline—PTGS1—kidney cancer	0.000239	0.236	CrCbGaD
Cyproheptadine—Clozapine—CYP1A1—kidney cancer	0.000163	0.161	CrCbGaD
Cyproheptadine—Carbamazepine—ABCB1—kidney cancer	0.000141	0.139	CrCbGaD
Cyproheptadine—Clozapine—ABCB1—kidney cancer	8.65e-05	0.0855	CrCbGaD
Cyproheptadine—Amitriptyline—ABCB1—kidney cancer	8.05e-05	0.0795	CrCbGaD
Cyproheptadine—HTR2B—Signaling by GPCR—PIK3CA—kidney cancer	1.87e-05	0.000186	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TSC2—kidney cancer	1.87e-05	0.000186	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HIF1A—kidney cancer	1.87e-05	0.000186	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CDKN1B—kidney cancer	1.86e-05	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TSC2—kidney cancer	1.86e-05	0.000185	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RAF1—kidney cancer	1.86e-05	0.000185	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RELA—kidney cancer	1.85e-05	0.000184	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	1.85e-05	0.000184	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TSC2—kidney cancer	1.84e-05	0.000183	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PIK3CA—kidney cancer	1.84e-05	0.000183	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	1.84e-05	0.000183	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ERBB2—kidney cancer	1.84e-05	0.000183	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KDR—kidney cancer	1.83e-05	0.000182	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK3—kidney cancer	1.83e-05	0.000182	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—kidney cancer	1.83e-05	0.000182	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—kidney cancer	1.82e-05	0.000181	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—kidney cancer	1.82e-05	0.000181	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MTOR—kidney cancer	1.81e-05	0.00018	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—BRAF—kidney cancer	1.8e-05	0.000179	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KDR—kidney cancer	1.8e-05	0.000179	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KDR—kidney cancer	1.8e-05	0.000179	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—BRAF—kidney cancer	1.79e-05	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KDR—kidney cancer	1.79e-05	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KDR—kidney cancer	1.78e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCND1—kidney cancer	1.78e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—JUN—kidney cancer	1.77e-05	0.000177	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KDR—kidney cancer	1.77e-05	0.000176	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CTNNB1—kidney cancer	1.76e-05	0.000175	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	1.75e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK1—kidney cancer	1.74e-05	0.000173	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PTEN—kidney cancer	1.72e-05	0.000171	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CDKN1B—kidney cancer	1.7e-05	0.000169	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KIT—kidney cancer	1.68e-05	0.000168	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APC—kidney cancer	1.68e-05	0.000168	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	1.67e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—kidney cancer	1.67e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—PIK3CA—kidney cancer	1.66e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KIT—kidney cancer	1.66e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APC—kidney cancer	1.66e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KIT—kidney cancer	1.65e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APC—kidney cancer	1.65e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—KRAS—kidney cancer	1.65e-05	0.000164	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APC—kidney cancer	1.65e-05	0.000164	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KIT—kidney cancer	1.65e-05	0.000164	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KIT—kidney cancer	1.64e-05	0.000163	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APC—kidney cancer	1.64e-05	0.000163	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—KRAS—kidney cancer	1.64e-05	0.000163	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KIT—kidney cancer	1.63e-05	0.000162	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APC—kidney cancer	1.63e-05	0.000162	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCND1—kidney cancer	1.62e-05	0.000161	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—JUN—kidney cancer	1.62e-05	0.000161	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	1.61e-05	0.00016	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	1.61e-05	0.00016	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—kidney cancer	1.6e-05	0.00016	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	1.59e-05	0.000158	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	1.58e-05	0.000158	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—BRAF—kidney cancer	1.58e-05	0.000158	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	1.58e-05	0.000157	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—kidney cancer	1.58e-05	0.000157	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—kidney cancer	1.57e-05	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	1.57e-05	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—kidney cancer	1.57e-05	0.000156	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTEN—kidney cancer	1.57e-05	0.000156	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—kidney cancer	1.56e-05	0.000156	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	1.56e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—BRAF—kidney cancer	1.56e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—BRAF—kidney cancer	1.56e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—kidney cancer	1.55e-05	0.000154	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—BRAF—kidney cancer	1.55e-05	0.000154	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—kidney cancer	1.55e-05	0.000154	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—BRAF—kidney cancer	1.55e-05	0.000154	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	1.54e-05	0.000153	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—BRAF—kidney cancer	1.53e-05	0.000152	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	1.52e-05	0.000151	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	1.51e-05	0.00015	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	1.51e-05	0.00015	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	1.51e-05	0.00015	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RAF1—kidney cancer	1.51e-05	0.00015	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	1.5e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RELA—kidney cancer	1.5e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RAF1—kidney cancer	1.5e-05	0.000149	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	1.5e-05	0.000149	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—kidney cancer	1.49e-05	0.000148	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RELA—kidney cancer	1.49e-05	0.000148	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB2—kidney cancer	1.49e-05	0.000148	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	1.48e-05	0.000148	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB2—kidney cancer	1.48e-05	0.000147	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MTOR—kidney cancer	1.47e-05	0.000146	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	1.47e-05	0.000146	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK3—kidney cancer	1.47e-05	0.000146	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MTOR—kidney cancer	1.46e-05	0.000145	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—KRAS—kidney cancer	1.45e-05	0.000144	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	1.44e-05	0.000144	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	1.44e-05	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	1.44e-05	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	1.43e-05	0.000142	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	1.43e-05	0.000142	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—kidney cancer	1.43e-05	0.000142	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—KRAS—kidney cancer	1.42e-05	0.000142	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—KRAS—kidney cancer	1.42e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	1.42e-05	0.000141	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—kidney cancer	1.42e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—KRAS—kidney cancer	1.41e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	1.4e-05	0.000139	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—kidney cancer	1.4e-05	0.000139	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	1.38e-05	0.000137	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	1.37e-05	0.000137	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—kidney cancer	1.35e-05	0.000134	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—kidney cancer	1.34e-05	0.000134	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK3—kidney cancer	1.34e-05	0.000133	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	1.33e-05	0.000133	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RAF1—kidney cancer	1.32e-05	0.000132	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—kidney cancer	1.32e-05	0.000131	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RELA—kidney cancer	1.32e-05	0.000131	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—kidney cancer	1.32e-05	0.000131	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—kidney cancer	1.31e-05	0.000131	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	1.31e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—kidney cancer	1.31e-05	0.00013	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—kidney cancer	1.31e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	1.31e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—kidney cancer	1.31e-05	0.00013	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	1.3e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	1.3e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—kidney cancer	1.3e-05	0.00013	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RAF1—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RAF1—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RELA—kidney cancer	1.3e-05	0.000129	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RAF1—kidney cancer	1.29e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RELA—kidney cancer	1.29e-05	0.000129	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RAF1—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RELA—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—kidney cancer	1.28e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RELA—kidney cancer	1.28e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	1.28e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RAF1—kidney cancer	1.28e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	1.28e-05	0.000127	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	1.27e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RELA—kidney cancer	1.27e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—kidney cancer	1.27e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—kidney cancer	1.27e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—kidney cancer	1.27e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—kidney cancer	1.26e-05	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	1.26e-05	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—kidney cancer	1.26e-05	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—kidney cancer	1.26e-05	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—kidney cancer	1.25e-05	0.000124	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	1.21e-05	0.00012	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	1.21e-05	0.00012	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—kidney cancer	1.2e-05	0.00012	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	1.19e-05	0.000119	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	1.19e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	1.19e-05	0.000118	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—kidney cancer	1.19e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	1.18e-05	0.000118	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—kidney cancer	1.17e-05	0.000117	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	1.17e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—kidney cancer	1.17e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—kidney cancer	1.16e-05	0.000116	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—kidney cancer	1.16e-05	0.000115	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—kidney cancer	1.16e-05	0.000115	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—kidney cancer	1.16e-05	0.000115	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—kidney cancer	1.15e-05	0.000115	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	1.15e-05	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—kidney cancer	1.15e-05	0.000114	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	1.14e-05	0.000114	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	1.14e-05	0.000114	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—kidney cancer	1.14e-05	0.000113	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—kidney cancer	1.13e-05	0.000113	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—kidney cancer	1.13e-05	0.000113	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—kidney cancer	1.13e-05	0.000113	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—kidney cancer	1.13e-05	0.000113	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—kidney cancer	1.13e-05	0.000112	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—kidney cancer	1.13e-05	0.000112	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	1.13e-05	0.000112	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—kidney cancer	1.13e-05	0.000112	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.12e-05	0.000112	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	1.12e-05	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—kidney cancer	1.12e-05	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	1.12e-05	0.000111	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—kidney cancer	1.12e-05	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—kidney cancer	1.11e-05	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.11e-05	0.00011	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	1.11e-05	0.00011	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—kidney cancer	1.1e-05	0.000109	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—kidney cancer	1.1e-05	0.000109	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—kidney cancer	1.09e-05	0.000109	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—kidney cancer	1.09e-05	0.000108	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	1.09e-05	0.000108	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	1.08e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.08e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—kidney cancer	1.07e-05	0.000106	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—kidney cancer	1.06e-05	0.000105	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—kidney cancer	1.05e-05	0.000104	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	1.03e-05	0.000103	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	1.03e-05	0.000102	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—kidney cancer	1.01e-05	0.0001	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	9.92e-06	9.86e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—kidney cancer	9.89e-06	9.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	9.86e-06	9.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	9.83e-06	9.78e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—kidney cancer	9.76e-06	9.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	9.74e-06	9.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—kidney cancer	9.71e-06	9.65e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—kidney cancer	9.53e-06	9.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	9.38e-06	9.33e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—kidney cancer	9.36e-06	9.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	9.33e-06	9.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	9.3e-06	9.25e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—kidney cancer	9.27e-06	9.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	9.21e-06	9.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—kidney cancer	9.18e-06	9.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—kidney cancer	9.12e-06	9.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—kidney cancer	9.1e-06	9.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—kidney cancer	9.07e-06	9.02e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—kidney cancer	9.07e-06	9.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—kidney cancer	9.05e-06	9e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	8.96e-06	8.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—kidney cancer	8.96e-06	8.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	8.92e-06	8.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	8.92e-06	8.87e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—kidney cancer	8.91e-06	8.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	8.88e-06	8.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	8.85e-06	8.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	8.76e-06	8.71e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—kidney cancer	8.67e-06	8.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—kidney cancer	8.63e-06	8.58e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—kidney cancer	8.57e-06	8.52e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—kidney cancer	8.43e-06	8.38e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—kidney cancer	8.41e-06	8.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—kidney cancer	8.38e-06	8.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—kidney cancer	8.36e-06	8.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—kidney cancer	8.28e-06	8.23e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	7.87e-06	7.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	7.74e-06	7.7e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	7.73e-06	7.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	7.7e-06	7.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	7.68e-06	7.64e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—kidney cancer	7.61e-06	7.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	7.6e-06	7.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—kidney cancer	7.49e-06	7.45e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—kidney cancer	7.48e-06	7.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—kidney cancer	7.45e-06	7.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—kidney cancer	7.43e-06	7.39e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—kidney cancer	7.36e-06	7.32e-05	CbGpPWpGaD
